Document is current
Any future updates will be listed below
-
Authors
Schulze, Friederike
Wehner, Josua
Kratschmar, Denise V.
Makshana, Valmir
Meier, Daniel T.
Häuselmann, Stéphanie P.
Dalmas, Elise
Thienel, Constanze
Dror, Erez
Wiedemann, Sophia J.
Traub, Shuyang
Nordmann, Thierry M.
Rachid, Leila
De Baat, Axel
Rohm, Theresa V.
Zhao, Cheng
Odermatt, Alex
Böni-Schnetzler, Marianne
Donath, Marc Y.
- License Information
-
More Information
Article History
Received: 20 November 2019
Accepted: 29 January 2020
First Online: 20 February 2020
Competing interests
: M.Y.D. is listed as the inventor on a patent filed in 2003 for the use of an IL-1 receptor antagonist for the treatment of or prophylaxis for type 2 diabetes WO2004002512 A1.
